WO2024261648 - MULTIVALENT SUBTYPE INFLUENZA VACCINE
National phase entry:
Publication Number
WO/2024/261648
Publication Date
26.12.2024
International Application No.
PCT/IB2024/055964
International Filing Date
19.06.2024
Title **
[English]
MULTIVALENT SUBTYPE INFLUENZA VACCINE
[French]
VACCIN CONTRE LA GRIPPE DE SOUS-TYPE MULTIVALENT
Applicants **
SEQIRUS INC.
Inventors
ROCKMAN, Steven
LAURIE, Karen
MCMAHON, Meagan
Priority Data
2023901936
19.06.2023
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3047 | |
| EPO | Filing, Examination, Granting | 24545 | |
| Japan | Filing, Examination, Granting | 2949 | |
| South Korea | Filing, Examination, Granting | 3800 | |
| USA | Filing, Examination, Granting | 10140 |
Total:
44,481
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to multivalent subtype influenza vaccines to treat and prevent influenza-associated diseases, disorders or conditions.[French]
La présente invention concerne des vaccins contre la grippe de sous-type multivalents pour traiter et prévenir des maladies, des troubles ou des états associés à la grippe.